ZJYL
Jin Medical International Ltd.
Medical - Instruments & Supplies
Market Cap$344M
5Y Perf.-70.5%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
ZJYL vs MPWR
Revenue, margins, valuation, and 5-year total return — side by side.
MPWR
Monolithic Power Systems, Inc.
Semiconductors
Market Cap$77.41B
5Y Perf.+214.9%
ZJYL vs MPWR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ZJYL | MPWR |
|---|---|---|
| Industry | Medical - Instruments & Supplies | Semiconductors |
| Market Cap | $344M | $77.41B |
| Revenue (TTM) | $43M | $2.79B |
| Net Income (TTM) | $5M | $616M |
| Gross Margin | 35.8% | 55.2% |
| Operating Margin | 10.0% | 26.1% |
| Forward P/E | 93.6x | 73.1x |
| Total Debt | $12M | $24M |
| Cash & Equiv. | $8M | $1.10B |
ZJYL vs MPWR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
ZJYL
MPWR
| Stock | Mar 23 | May 26 | Return |
|---|---|---|---|
| Jin Medical Interna… (ZJYL) | 100 | 29.5 | -70.5% |
| Monolithic Power Sy… (MPWR) | 100 | 314.9 | +214.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ZJYL vs MPWR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MPWR leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Jin Medical International Ltd. is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ZJYL
Jin Medical International Ltd.
The Income Pick
ZJYL is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 1.57
- Lower volatility, beta 1.57, Low D/E 40.6%, current ratio 2.50x
- Beta 1.57, current ratio 2.50x
Best for: income & stability and sleep-well-at-night
MPWR
Monolithic Power Systems, Inc.
The Growth Play
MPWR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 26.4%, EPS growth -65.2%, 3Y rev CAGR 15.9%
- 24.9% 10Y total return vs ZJYL's -72.3%
- PEG 2.48 vs ZJYL's 4.48
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | MPWR | 26.4% revenue growth vs ZJYL's 18.6% |
| Value | MPWR | Lower P/E (73.1x vs 93.6x), PEG 2.48 vs 4.48 |
| Quality / Margins | MPWR | 22.1% margin vs ZJYL's 10.9% |
| Stability / Safety | ZJYL | Beta 1.57 vs MPWR's 2.28 |
| Dividends | MPWR | 0.4% yield; 8-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | MPWR | +148.6% vs ZJYL's -86.4% |
| Efficiency (ROA) | MPWR | 15.2% ROA vs ZJYL's 9.7%, ROIC 22.2% vs 10.3% |
ZJYL vs MPWR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2023
ZJYL vs MPWR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLMPWRLAGGINGZJYL
ZJYLJin Medical Internati…
1leads
MPWRMonolithic Power Syst…
3leads
6 Total Categories
CATEGORYLEADERvs ZJYLMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
MPWR6/6
Valuation MetricsMultiples, price ratios, and targets
ZJYL4/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
MPWR7/8
Total Returns1Y, 3Y, 5Y total returns with dividends
MPWR6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
MPWR leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MPWR is the larger business by revenue, generating $2.8B annually — 65.0x ZJYL's $43M. MPWR is the more profitable business, keeping 22.1% of every revenue dollar as net income compared to ZJYL's 10.9%. On growth, MPWR holds the edge at +20.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ZJYLJin Medical Inter… | MPWRMonolithic Power … |
|---|---|---|
| RevenueTrailing 12 months | $43M | $2.8B |
| EBITDAEarnings before interest/tax | $5M | $781M |
| Net IncomeAfter-tax profit | $5M | $616M |
| Free Cash FlowCash after capex | -$581,373 | $664M |
| Gross MarginGross profit ÷ Revenue | +35.8% | +55.2% |
| Operating MarginEBIT ÷ Revenue | +10.0% | +26.1% |
| Net MarginNet income ÷ Revenue | +10.9% | +22.1% |
| FCF MarginFCF ÷ Revenue | -1.4% | +23.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.4% | +20.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -105.3% | -88.4% |
MPWR leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
ZJYL leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
At 93.6x trailing earnings, ZJYL trades at a 24% valuation discount to MPWR's 123.6x P/E. Adjusting for growth (PEG ratio), MPWR offers better value at 4.19x vs ZJYL's 4.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ZJYLJin Medical Inter… | MPWRMonolithic Power … |
|---|---|---|
| Market CapShares × price | $344M | $77.4B |
| Enterprise ValueMkt cap + debt − cash | $348M | $76.3B |
| Trailing P/EPrice ÷ TTM EPS | 93.62x | 123.60x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 73.12x |
| PEG RatioP/E ÷ EPS growth rate | 4.48x | 4.19x |
| EV / EBITDAEnterprise value multiple | 87.30x | 97.90x |
| Price / SalesMarket cap ÷ Revenue | 14.65x | 27.74x |
| Price / BookPrice ÷ Book value/share | 12.06x | 21.56x |
| Price / FCFMarket cap ÷ FCF | — | 116.20x |
ZJYL leads this category, winning 4 of 5 comparable metrics.
Profitability & Efficiency
MPWR leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
MPWR delivers a 17.9% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $17 for ZJYL. MPWR carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ZJYL's 0.41x. On the Piotroski fundamental quality scale (0–9), MPWR scores 6/9 vs ZJYL's 2/9, reflecting solid financial health.
| Metric | ZJYLJin Medical Inter… | MPWRMonolithic Power … |
|---|---|---|
| ROE (TTM)Return on equity | +16.9% | +17.9% |
| ROA (TTM)Return on assets | +9.7% | +15.2% |
| ROICReturn on invested capital | +10.3% | +22.2% |
| ROCEReturn on capital employed | +13.8% | +20.4% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 |
| Debt / EquityFinancial leverage | 0.41x | 0.01x |
| Net DebtTotal debt minus cash | $3M | -$1.1B |
| Cash & Equiv.Liquid assets | $8M | $1.1B |
| Total DebtShort + long-term debt | $12M | $24M |
| Interest CoverageEBIT ÷ Interest expense | 20.63x | — |
MPWR leads this category, winning 7 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
MPWR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MPWR five years ago would be worth $46,617 today (with dividends reinvested), compared to $2,767 for ZJYL. Over the past 12 months, MPWR leads with a +148.6% total return vs ZJYL's -86.4%. The 3-year compound annual growth rate (CAGR) favors MPWR at 56.1% vs ZJYL's -26.8% — a key indicator of consistent wealth creation.
| Metric | ZJYLJin Medical Inter… | MPWRMonolithic Power … |
|---|---|---|
| YTD ReturnYear-to-date | -51.1% | +68.5% |
| 1-Year ReturnPast 12 months | -86.4% | +148.6% |
| 3-Year ReturnCumulative with dividends | -60.7% | +280.3% |
| 5-Year ReturnCumulative with dividends | -72.3% | +366.2% |
| 10-Year ReturnCumulative with dividends | -72.3% | +2494.7% |
| CAGR (3Y)Annualised 3-year return | -26.8% | +56.1% |
MPWR leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — ZJYL and MPWR each lead in 1 of 2 comparable metrics.
Risk & Volatility
ZJYL is the less volatile stock with a 1.57 beta — it tends to amplify market swings less than MPWR's 2.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MPWR currently trades 94.8% from its 52-week high vs ZJYL's 12.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ZJYLJin Medical Inter… | MPWRMonolithic Power … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.57x | 2.28x |
| 52-Week HighHighest price in past year | $18.00 | $1662.00 |
| 52-Week LowLowest price in past year | $0.12 | $613.00 |
| % of 52W HighCurrent price vs 52-week peak | +12.2% | +94.8% |
| RSI (14)Momentum oscillator 0–100 | 53.7 | 71.0 |
| Avg Volume (50D)Average daily shares traded | 22K | 577K |
Evenly matched — ZJYL and MPWR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
MPWR is the only dividend payer here at 0.37% yield — a key consideration for income-focused portfolios.
| Metric | ZJYLJin Medical Inter… | MPWRMonolithic Power … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $1615.00 |
| # AnalystsCovering analysts | — | 25 |
| Dividend YieldAnnual dividend ÷ price | — | +0.4% |
| Dividend StreakConsecutive years of raises | — | 8 |
| Dividend / ShareAnnual DPS | — | $5.90 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
MPWR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ZJYL leads in 1 (Valuation Metrics). 1 tied.
Best OverallMonolithic Power Systems, I… (MPWR)Leads 3 of 6 categories
Loading custom metrics...
ZJYL vs MPWR: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ZJYL or MPWR a better buy right now?
For growth investors, Monolithic Power Systems, Inc.
(MPWR) is the stronger pick with 26. 4% revenue growth year-over-year, versus 18. 6% for Jin Medical International Ltd. (ZJYL). Jin Medical International Ltd. (ZJYL) offers the better valuation at 93. 6x trailing P/E, making it the more compelling value choice. Analysts rate Monolithic Power Systems, Inc. (MPWR) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ZJYL or MPWR?
On trailing P/E, Jin Medical International Ltd.
(ZJYL) is the cheapest at 93. 6x versus Monolithic Power Systems, Inc. at 123. 6x.
03Which is the better long-term investment — ZJYL or MPWR?
Over the past 5 years, Monolithic Power Systems, Inc.
(MPWR) delivered a total return of +366. 2%, compared to -72. 3% for Jin Medical International Ltd. (ZJYL). Over 10 years, the gap is even starker: MPWR returned +24. 9% versus ZJYL's -72. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ZJYL or MPWR?
By beta (market sensitivity over 5 years), Jin Medical International Ltd.
(ZJYL) is the lower-risk stock at 1. 57β versus Monolithic Power Systems, Inc. 's 2. 28β — meaning MPWR is approximately 45% more volatile than ZJYL relative to the S&P 500. On balance sheet safety, Monolithic Power Systems, Inc. (MPWR) carries a lower debt/equity ratio of 1% versus 41% for Jin Medical International Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — ZJYL or MPWR?
By revenue growth (latest reported year), Monolithic Power Systems, Inc.
(MPWR) is pulling ahead at 26. 4% versus 18. 6% for Jin Medical International Ltd. (ZJYL). On earnings-per-share growth, the picture is similar: Jin Medical International Ltd. grew EPS 18. 7% year-over-year, compared to -65. 2% for Monolithic Power Systems, Inc.. Over a 3-year CAGR, MPWR leads at 15. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ZJYL or MPWR?
Monolithic Power Systems, Inc.
(MPWR) is the more profitable company, earning 22. 1% net margin versus 15. 6% for Jin Medical International Ltd. — meaning it keeps 22. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MPWR leads at 26. 1% versus 15. 5% for ZJYL. At the gross margin level — before operating expenses — MPWR leads at 55. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — ZJYL or MPWR?
In this comparison, MPWR (0.
4% yield) pays a dividend. ZJYL does not pay a meaningful dividend and should not be held primarily for income.
08Is ZJYL or MPWR better for a retirement portfolio?
For long-horizon retirement investors, Jin Medical International Ltd.
(ZJYL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Monolithic Power Systems, Inc. (MPWR) carries a higher beta of 2. 28 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ZJYL: -72. 3%, MPWR: +24. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ZJYL and MPWR?
These companies operate in different sectors (ZJYL (Healthcare) and MPWR (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(ZJYL: -6.4% · MPWR: 20.8%)Net Margin>
%
(ZJYL: 10.9% · MPWR: 22.1%)P/E Ratio<
x
(ZJYL: 93.6x · MPWR: 123.6x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.